Amgen IncNASDAQ:AMGN
- LAST PRICE299.8850
- TODAY'S CHANGE (%)0.4050 (0.1352%)
- Bid / Lots299.8000/ 4
- Ask / Lots299.9700/ 2
- Open / Previous Close301.7500 / 299.4800
- Day Range
- 52 Week Range
- Volume1,168,240
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMGN |
|---|---|---|
| 09:32 ET | 64699 | 300.02 |
| 09:34 ET | 8253 | 301.36 |
| 09:36 ET | 14807 | 300.1103 |
| 09:38 ET | 8191 | 301.03 |
| 09:39 ET | 4650 | 301.065 |
| 09:41 ET | 8191 | 301.54 |
| 09:43 ET | 5705 | 301.695 |
| 09:45 ET | 2695 | 301.49 |
| 09:48 ET | 4973 | 301.96 |
| 09:50 ET | 9628 | 302.62 |
| 09:52 ET | 14961 | 302.4 |
| 09:54 ET | 7066 | 302.29 |
| 09:56 ET | 3918 | 301.4269 |
| 09:57 ET | 2660 | 301.3 |
| 09:59 ET | 7155 | 301.48 |
| 10:01 ET | 22121 | 301.05 |
| 10:03 ET | 8829 | 301.12 |
| 10:06 ET | 7391 | 301.26 |
| 10:08 ET | 7324 | 301 |
| 10:10 ET | 12731 | 301.485 |
| 10:12 ET | 18339 | 301.07 |
| 10:14 ET | 1587 | 300.95 |
| 10:15 ET | 2781 | 300.595 |
| 10:17 ET | 6395 | 300.48 |
| 10:19 ET | 5405 | 300.805 |
| 10:21 ET | 4303 | 300.48 |
| 10:24 ET | 4898 | 300.165 |
| 10:26 ET | 11986 | 300.575 |
| 10:28 ET | 6889 | 300.79 |
| 10:30 ET | 1758 | 301.1 |
| 10:32 ET | 3974 | 301.34 |
| 10:33 ET | 2211 | 301.04 |
| 10:35 ET | 2565 | 300.98 |
| 10:37 ET | 3900 | 301.5 |
| 10:39 ET | 3576 | 301.39 |
| 10:42 ET | 3671 | 301.5 |
| 10:44 ET | 4181 | 301.64 |
| 10:46 ET | 5556 | 301.265 |
| 10:48 ET | 4602 | 301.25 |
| 10:50 ET | 2000 | 301.55 |
| 10:51 ET | 7491 | 301.5 |
| 10:53 ET | 5576 | 301.78 |
| 10:55 ET | 2394 | 301.78 |
| 10:57 ET | 3675 | 301.78 |
| 11:00 ET | 2093 | 301.835 |
| 11:02 ET | 5199 | 301.53 |
| 11:04 ET | 3069 | 301.29 |
| 11:06 ET | 1600 | 301.53 |
| 11:08 ET | 2126 | 301.59 |
| 11:09 ET | 8826 | 302.04 |
| 11:11 ET | 5000 | 301.9993 |
| 11:13 ET | 800 | 302.035 |
| 11:15 ET | 3814 | 302.245 |
| 11:18 ET | 10778 | 302.125 |
| 11:20 ET | 12214 | 302.49 |
| 11:22 ET | 8021 | 302.27 |
| 11:24 ET | 2235 | 302.24 |
| 11:26 ET | 2002 | 302.105 |
| 11:27 ET | 6787 | 302.21 |
| 11:29 ET | 4623 | 301.94 |
| 11:31 ET | 9918 | 301.95 |
| 11:33 ET | 7865 | 301.725 |
| 11:36 ET | 4477 | 301.9939 |
| 11:38 ET | 2409 | 301.87 |
| 11:40 ET | 5571 | 301.97 |
| 11:42 ET | 4002 | 302.39 |
| 11:44 ET | 1900 | 302.53 |
| 11:45 ET | 3927 | 302.75 |
| 11:47 ET | 3032 | 302.59 |
| 11:49 ET | 6110 | 302.76 |
| 11:51 ET | 842 | 302.7378 |
| 11:54 ET | 3951 | 302.3 |
| 11:56 ET | 1314 | 302.39 |
| 11:58 ET | 17696 | 301.72 |
| 12:00 ET | 10201 | 301.16 |
| 12:02 ET | 8857 | 300.91 |
| 12:03 ET | 2668 | 300.87 |
| 12:05 ET | 3316 | 300.175 |
| 12:07 ET | 3067 | 300.15 |
| 12:09 ET | 3939 | 300.1655 |
| 12:12 ET | 4299 | 300.045 |
| 12:14 ET | 1704 | 300.07 |
| 12:16 ET | 2053 | 300.19 |
| 12:18 ET | 6167 | 299.7964 |
| 12:20 ET | 1835 | 299.55 |
| 12:21 ET | 3838 | 299.81 |
| 12:23 ET | 2755 | 299.8899 |
| 12:25 ET | 2797 | 299.98 |
| 12:27 ET | 2821 | 300.042 |
| 12:30 ET | 3292 | 300.045 |
| 12:32 ET | 1400 | 299.9722 |
| 12:34 ET | 3100 | 299.7226 |
| 12:36 ET | 5041 | 299.615 |
| 12:38 ET | 4233 | 299.66 |
| 12:39 ET | 2542 | 299.1298 |
| 12:41 ET | 7655 | 299.51 |
| 12:43 ET | 3871 | 299.38 |
| 12:45 ET | 1497 | 299.321 |
| 12:48 ET | 2550 | 299.61 |
| 12:50 ET | 3342 | 299.61 |
| 12:52 ET | 800 | 299.72 |
| 12:54 ET | 2348 | 299.83 |
| 12:56 ET | 3625 | 299.91 |
| 12:57 ET | 4779 | 300.28 |
| 12:59 ET | 3831 | 300.2017 |
| 01:01 ET | 2275 | 300.23 |
| 01:03 ET | 900 | 300.46 |
| 01:06 ET | 1893 | 300.3352 |
| 01:08 ET | 1481 | 300.26 |
| 01:10 ET | 1959 | 300 |
| 01:12 ET | 3400 | 299.525 |
| 01:14 ET | 750 | 299.47 |
| 01:15 ET | 3754 | 299.715 |
| 01:17 ET | 4581 | 299.66 |
| 01:19 ET | 2234 | 299.6335 |
| 01:21 ET | 1445 | 299.86 |
| 01:24 ET | 1534 | 299.825 |
| 01:26 ET | 2104 | 299.5 |
| 01:28 ET | 2781 | 299.805 |
| 01:30 ET | 2951 | 299.87 |
| 01:32 ET | 5330 | 299.885 |
Yesterday
DJ Amgen Down Over 13%, Worst Performer in the DJIA and Nasdaq 100 So Far Today -- Data Talk, from 12:05PM ET on Monday May 06, 2024 by Dow Jones
12:05PM ET on Monday May 06, 2024 by Dow Jones
May 3, 2024
DJ These Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More -- Barrons.com, from 4:51PM ET on Friday May 03, 2024 by Dow Jones
4:51PM ET on Friday May 03, 2024 by Dow JonesDJ Amgen Is Maintained at Outperform by RBC Capital, from 1:23PM ET on Friday May 03, 2024 by Dow Jones
1:23PM ET on Friday May 03, 2024 by Dow JonesDJ Amgen Is Maintained at Equal-Weight by Morgan Stanley, from 1:16PM ET on Friday May 03, 2024 by Dow Jones
1:16PM ET on Friday May 03, 2024 by Dow JonesDJ Amgen Is Maintained at Neutral by UBS, from 12:10PM ET on Friday May 03, 2024 by Dow Jones
12:10PM ET on Friday May 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amgen Inc | 160.6B | 42.9x | -0.22% |
Gilead Sciences Inc | 81.7B | 183.1x | +1.53% |
Novartis AG | 213.1B | 22.5x | -5.59% |
GSK plc | 90.1B | 16.1x | +6.39% |
Bristol-Myers Squibb Co | 89.0B | -14.2x | +4.90% |
Pfizer Inc | 159.5B | -460.6x | -7.10% |
Company Information
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Contact Information
- Headquarters
- One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
- Phone
- 805-447-1000
- Fax
- 805-447-1010
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Bradway
- Chief Financial Officer, Executive Vice President
- Peter Griffith
- Executive Vice President, Chief Technology Officer
- David Reese
- Executive Vice President, Research and Development, and Chief Scientific Officer
- James Bradner
- Executive Vice President, General Counsel, Secretary
- Jonathan Graham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $160.6B |
|---|---|
Revenue (TTM) | $29.5B |
Shares Outstanding | 536.4M |
Dividend Yield | 3.00% |
Annual Dividend Rate | 9.0000 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-07-24 |
Beta | 0.59 |
EPS | $7.00 |
Book Value | $11.64 |
P/E Ratio | 42.9x |
Price/Sales (TTM) | 5.4 |
Price/Cash Flow (TTM) | 19.3x |
Operating Margin | 23.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
